HK1096103A1 - Anti-epcam immunoglobulins - Google Patents

Anti-epcam immunoglobulins

Info

Publication number
HK1096103A1
HK1096103A1 HK07102075.7A HK07102075A HK1096103A1 HK 1096103 A1 HK1096103 A1 HK 1096103A1 HK 07102075 A HK07102075 A HK 07102075A HK 1096103 A1 HK1096103 A1 HK 1096103A1
Authority
HK
Hong Kong
Prior art keywords
immunoglobulin
human
administering
frequently
once
Prior art date
Application number
HK07102075.7A
Other languages
English (en)
Inventor
Malte Peters
Mathias Locher
Nadja Prang
Cornelia Quadt
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Publication of HK1096103A1 publication Critical patent/HK1096103A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK07102075.7A 2004-02-13 2007-02-23 Anti-epcam immunoglobulins HK1096103A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins
PCT/EP2005/001307 WO2005080428A2 (en) 2004-02-13 2005-02-09 Anti-epcam immunoglobulins

Publications (1)

Publication Number Publication Date
HK1096103A1 true HK1096103A1 (en) 2007-05-25

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07102075.7A HK1096103A1 (en) 2004-02-13 2007-02-23 Anti-epcam immunoglobulins

Country Status (24)

Country Link
US (3) US20050180979A1 (xx)
EP (2) EP1713830B1 (xx)
JP (1) JP5220315B2 (xx)
KR (1) KR101236224B1 (xx)
CN (1) CN1976951B (xx)
AT (1) ATE437186T1 (xx)
AU (1) AU2005215874B2 (xx)
BR (1) BRPI0507660A (xx)
CA (1) CA2555694C (xx)
DE (1) DE602005015544D1 (xx)
DK (1) DK1713830T3 (xx)
EA (1) EA011951B1 (xx)
ES (1) ES2328159T3 (xx)
HK (1) HK1096103A1 (xx)
IL (1) IL177069A (xx)
MX (1) MXPA06008942A (xx)
NO (1) NO339364B1 (xx)
NZ (1) NZ549125A (xx)
PL (1) PL1713830T3 (xx)
PT (1) PT1713830E (xx)
SI (1) SI1713830T1 (xx)
UA (1) UA87128C2 (xx)
WO (1) WO2005080428A2 (xx)
ZA (1) ZA200606083B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169516B2 (en) 2003-01-24 2015-10-27 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
EP1981539B1 (en) * 2006-02-09 2014-07-23 Amgen Research (Munich) GmbH Treatment of metastatic breast cancer
EP1865001A1 (en) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Specific protease inhibitors and their use in cancer therapy
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
ATE512988T1 (de) 2007-04-04 2011-07-15 Sigma Tau Ind Farmaceuti Antikörper gegen epcam und anwendungen davon
CN107083444B (zh) 2008-12-22 2023-03-14 犹他大学研究基金会 单色多重定量pcr
AU2010295172B2 (en) * 2009-09-21 2016-08-04 Ranju Ralhan Methods and compositions for the diagnosis and treatment of thyroid cancer
WO2013131001A1 (en) * 2012-03-02 2013-09-06 Academia Sinica ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF
CN103387988B (zh) * 2012-09-24 2016-01-06 厦门大学 上皮细胞粘附分子的核酸适体EpCAM Ccut及其制备方法
US10316366B2 (en) 2013-05-22 2019-06-11 Telomere Diagnostics, Inc. Measures of short telomere abundance
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
WO2016108954A1 (en) 2014-12-30 2016-07-07 Telomere Diagnostics, Inc. Multiplex quantitative pcr
CN112807429A (zh) * 2015-11-19 2021-05-18 雷维托普有限公司 用于对非所要细胞进行重定向杀灭的两组分系统的功能性抗体片段互补作用
JP2019530431A (ja) 2016-07-26 2019-10-24 テッサ・セラピューティクス・プライベート・リミテッド キメラ抗原受容体
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
TR199902553T2 (xx) * 1997-04-14 2000-03-21 Micromet Gesellschaft F�R Biomedizinische Forschung Mbh �nsan v�cuduna kar�� antijen resept�rlerinin �retimi i�in yeni metod ve kullan�mlar�.
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
CN100503639C (zh) * 2001-05-03 2009-06-24 默克专利有限公司 重组肿瘤特异性抗体及其应用
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
EP1575491A4 (en) * 2002-05-20 2006-09-27 Abgenix Inc TREATMENT OF RENAL CARCINOMA USING ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR

Also Published As

Publication number Publication date
PT1713830E (pt) 2009-10-19
WO2005080428A2 (en) 2005-09-01
CA2555694C (en) 2013-04-16
AU2005215874B2 (en) 2011-01-27
MXPA06008942A (es) 2007-01-26
IL177069A0 (en) 2006-12-10
JP2008500277A (ja) 2008-01-10
ES2328159T3 (es) 2009-11-10
NO339364B1 (no) 2016-12-05
EP1713830A2 (en) 2006-10-25
UA87128C2 (ru) 2009-06-25
EA011951B1 (ru) 2009-06-30
KR20070009988A (ko) 2007-01-19
EP1713830B1 (en) 2009-07-22
DK1713830T3 (da) 2009-10-12
ATE437186T1 (de) 2009-08-15
IL177069A (en) 2010-11-30
KR101236224B1 (ko) 2013-02-22
US20050180979A1 (en) 2005-08-18
CA2555694A1 (en) 2005-09-01
CN1976951B (zh) 2012-03-14
JP5220315B2 (ja) 2013-06-26
NZ549125A (en) 2008-09-26
EA200601386A1 (ru) 2007-06-29
DE602005015544D1 (de) 2009-09-03
EP2107071A2 (en) 2009-10-07
US20070274982A1 (en) 2007-11-29
PL1713830T3 (pl) 2010-01-29
SI1713830T1 (sl) 2009-10-31
CN1976951A (zh) 2007-06-06
ZA200606083B (en) 2007-10-31
AU2005215874A1 (en) 2005-09-01
US20120294873A1 (en) 2012-11-22
NO20064136L (no) 2006-11-07
BRPI0507660A (pt) 2007-07-17
WO2005080428A3 (en) 2005-11-10
EP2107071A3 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
HK1096103A1 (en) Anti-epcam immunoglobulins
HK1094167A1 (en) Monoclonal antibodies to hepatocyte growth factor
RS20060234A (xx) Potpuno humana antitela za humani 4-1bb (cd137)
DK1684869T3 (da) Fremgangsmåde til terapi af B-celle-relaterede cancersygdomme
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
PL401886A1 (pl) Neutralizujace o wysokim powinowactwie izolowane ludzkie przeciwcialo anty-TNF-alfa, zastosowanie tego przeciwciala, krysztal zawierajacy ludzkie przeciwcialo anty-TNF-alfa i preparat zawierajacy ten krysztal
WO2003076585A3 (en) Controlled modulation of amino acid side chain length of peptide antigens
EA200970262A1 (ru) Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам
UA87093C2 (ru) ГУМАНИЗИРОВАННЫЙ ИММУНОГЛОБУЛИН, КОТОРЫЙ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С БЕТА-АМИЛОИДНЫМ ПЕПТИДОМ (Аβ)
MY145042A (en) Humanized monoclonal antibodies to hepatocyte growth factor
TW200517124A (en) Fully human antibodies against human 4-1BB
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
DK1684770T3 (da) Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræft
PL376964A1 (pl) Leczenie miażdżycy tętnic przez bierne uodpornienie peptydem
WO2003097082A3 (en) Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
SG156658A1 (en) Treatment of diseases
WO2005000406A3 (en) Treatment of amyloid- and epileptogenesis-associated diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190206